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Background
Tetherin (BST-2) is an interferon-inducible transmem-
brane protein that inhibits the release of enveloped
viruses from infected cells. Here, we characterise the
feline homologue of tetherin and assess its effects on
the replication of feline immunodeficiency virus (FIV).
Results
A feline homologue of tetherin was amplified from IL2-
dependent T cell cDNA. Real-time PCR analyses
revealed that feline tetherin transcripts were expressed
in many feline cell lines and were induced by interferons
(a, ω or g). Like human tetherin, feline tetherin dis-
played potent inhibition of FIV and HIV-1 particle
release, however, this activity resisted antagonism by
either HIV-1 VPU, or the FIV Env and “OrfA” proteins.
Further, as over-expression of a complete FIV genome
in trans could not overcome feline tetherin, these data
suggest that FIV lacks a functional tetherin antagonist.
When expressed stably in feline cell lines, tetherin did
not abrogate the replication of FIV, indeed, syncytia for-
mation was significantly enhanced in tetherin-expressing
cells infected with CD134-independent strains of FIV
(FIV Fca-F14 and FIV Pco-CoLV). Confocal microscopy
revealed co-localisation of tetherin and FIV envelope
glycoprotein (Env) in regions at the periphery of syncy-
tia. Moreover, while treatment of feline cells with ínter-
feron-ω suppressed viral protein production and release
(consistent with the pleiotropic actions of type-l inter-
feron on viral replication), syncytia formation was
enhanced in cells treated with interferon-ω either pre-
or post- infection with a CD134-independent strain of
FIV.
Conclusions
While feline tetherin prevents the release of nascent
viral particles, cell to cell spread remains efficient in the
presence of abundant viral receptors and interferon-
induced up-regulation of tetherin expression may
enhance syncytia formation. Accordingly, tetherin
expression in vivo may promote the selective expansion
of viral variants capable of more efficient cell to cell
spread; contributing to the emergence of CD134-inde-
pendent strains of FIV.
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